Valproic Acid Teratogenicity: A Toxicogenomics Approach
- 3 June 2004
- journal article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 112 (12) , 1225-1235
- https://doi.org/10.1289/ehp.7034
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- In Situ-Synthesized Novel Microarray Optimized for Mouse Stem Cell and Early Developmental Expression ProfilingGenome Research, 2003
- Sp Family of Transcription Factors Is Involved in Valproic Acid-induced Expression of Gαi2Published by Elsevier ,2003
- Anti‐tumor mechanisms of valproate: A novel role for an old drugMedicinal Research Reviews, 2002
- Toxicology and genetic toxicology in the new era of “toxicogenomics”: impact of “-omics” technologiesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2001
- Annexin A11 (ANXA11) Gene Structure as the Progenitor of Paralogous Annexins and Source of Orthologous cDNA IsoformsGenomics, 2000
- Vitamin E decreases valproic acid induced neural tube defects in miceNeuroscience Letters, 2000
- Regulation of metallothionein gene expression by oxidative stress and metal ionsBiochemical Pharmacology, 1999
- Altered zinc metabolism contributes to the developmental toxicity of 2-ethylhexanoic acid, 2-ethylhexanol and valproic acidToxicology, 1998
- Butyrate selectively activates the metallothionein gene in teratocarcinoma cells and induces hypersensitivity to metal inductionNucleic Acids Research, 1987
- Synthesis of rat hepatic zinc thionein in response to the stress of sham operationLife Sciences, 1981